Insiders Exagen Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:30:01 2024-04-29 pm EDT			5-day change	1st Jan Change
1.41 ^USD	-0.15%		+0.71%	-29.15%

Apr. 26	Exagen Inc. Announces Changes in Board of Directors	CI
Mar. 18	Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Exagen Inc. Announces Changes in Board of Directors	Apr. 26	CI
Exagen Inc. Appoints Paul Kim as Class II Director	23-07-24	CI
Exagen Inc. Announces Board Changes	23-03-23	CI
Exagen Inc. Announces Board Changes	23-01-23	CI
Insider Buy: Exagen	22-12-09	MT
Exagen Inc. Announces Executive Changes	22-12-05	CI
Exagen Names John Aballi Chief Executive	22-10-17	MT
Exagen Inc. Appoints John Aballi as President	22-10-17	CI
Exagen Inc. Appoints John Aballi as CEO	22-10-17	CI
Exagen Inc. Appoints Andrew L. Concoff as Chief Innovation Officer	22-10-04	CI
Exagen Inc. Announces Board Appointments	22-03-16	CI
Exagen Inc. Appoints Ana Hooker to Board of Directors	21-07-30	CI
Exagen Elects Frank Stokes to Board of Directors	21-06-18	CI
Exagen Inc. Announces Resignation of Chet Burrell from the Board, Effective December 31, 2020	20-11-10	CI
Exagen Inc. Appoints Wendy Johnson as a Class III Director, and to Audit Committee Effective as of October 1, 2020	20-09-23	CI
Exagen Inc. Announces Executive Changes	20-03-24	CI
Exagen Inc. Forms Scientific Advisory Board	19-12-10	CI
Exagen Inc. Announces Resignation of Thierry Dervieux as Chief Scientific Officer, Effective December 9, 2019	19-11-22	CI
Exagen Inc. Expands Board of Directors with Its Appointment of Chet Burrell, Tina Nova and Bruce Robertson	19-07-30	CI
Exagen Inc. Appoints Jeff Elliott as Director	19-03-26	CI

No results for this search